Verily

Views & Analysis

Verily, Novartis join fund to support Europe’s biotech entre...

New $300m fund aimed at helping European biotechs to grow, providing alternative to an IPO or 'generally suboptimal' licensing or big pharma acquisition

Views & Analysis

Digital health round-up: Apple ventures into the Land of Nod

Apple becomes first 'big tech' firm to investigate sleep technology.

News

Verily launches ambitious Project Baseline

Study will create a comprehensive database reference for researchers.

News

Verily unveils the Study Watch, a clinical trials-only weara...

Device will be used in several upcoming clinical studies.

Views & Analysis

Why Novartis and Verily should abandon their smart lens idea

Technical officer hinted that the firm has hit obstacles to its ambitious projects.

Views & Analysis

Shallow focus photo of a patient charts with focus on the middle

Digital Health Round-up: Can digital resolve NHS' data secur...

A round-up of this week's digital healthcare news. Marco Ricci reports.

Verily, Novartis join fund to support Europe’s biotech entre...

Digital health round-up: Apple ventures into the Land of Nod

Verily launches ambitious Project Baseline

Verily unveils the Study Watch, a clinical trials-only weara...

Why Novartis and Verily should abandon their smart lens idea

Digital Health Round-up: Can digital resolve NHS' data secur...

CDMOs: Their crucial role and how to select one, with Sigma ...

How to meet your physicians where they are online

Verily

Editor's Picks